Pharma channel feed – Endpoints News

Pharma channel feed

Sumitomo’s overactive bladder drug adds another indication

4 months ago

FDA approves Lilly's Zepbound for sleep apnea, likely cracking open Medicare market

4 months ago

Novo Nordisk’s once-daily hemophilia drug Alhemo approved in US

4 months ago

Vertex gets 'vanza triple' approval and Trikafta expansion — with boxed warnings

4 months ago

PBM reform unlikely to attach to short-term spending bill as shutdown looms

4 months ago

Accelerated approval brings Pfizer's BRAF inhibitor to first-line patients

4 months ago

Rhythm receives expanded approval for genetic obesity drug

4 months ago

Xcovery nabs first FDA approval for lung cancer drug

4 months ago

Mesoblast wins long-awaited approval for cell therapy

4 months ago

Payers generally meet drug price watchdog's 'fair access' standards, report says

4 months ago

Regeneron forges ahead in factor XI despite field’s mixed results

4 months ago

In blow to compounders, FDA reaffirms tirzepatide shortage is over

4 months ago

The Endpoints 2024 winners and losers list: Who was up and who was down in biopharma

4 months ago

US spent $450B on drugs last year, CMS says, with new obesity and diabetes drugs adding to total

4 months ago

Novartis, AbbVie and PhRMA secure 340B court win in West Virginia

4 months ago

Merck’s long-awaited obesity move is an oral GLP-1 from China

4 months ago

Novartis turns to BioAge for new targets based on longevity and exercise

4 months ago

Jazz Pharmaceuticals CEO and co-founder Bruce Cozadd is retiring

4 months ago

Major PBM reforms feature in Congress' year-end spending bill

4 months ago

Sandoz inks $275M settlement in generic antitrust litigation

4 months ago

Pfizer’s message to investors: The ship is steadying in 2025 (even if Washington is turbulent)

4 months ago

How a duty to spend wisely on worker benefits could loosen PBMs' grip on drug prices

4 months ago

FDA rejects J&J’s subcutaneous Rybrevant over manufacturing issues

4 months ago

AstraZeneca is denied full FDA approval of Andexxa following critical advisory meeting

4 months ago

First page Previous page 17 18 192021 22 23 Next page Last page